Tag: Eli Lilly October 20, 2020 Startup company founded by Washington University scientists acquired by Eli LillyDrugmaker purchases Disarm Therapeutics to develop treatments for neurodegenerative diseases.Medical Campus & Community February 10, 2020 Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicatesTop-line data reported from international trial.News Release Posts navigation